General Healthcare News | Tissuepathology.com

Roche enters into a definitive merger agreement to acquire PathAI to transform AI-driven diagnostics

Erica Goodpaster — Thu, 07 May 2026 13:26:42 +0000

PathAI’s best-in-class Image Management System (IMS) with advanced AI analysis and workflow capabilities will complement Roche’s digital pathology portfolio to drive laboratory efficiency Combining Roche’s strong position in companion diagnostics and PathAI’s advanced AI platform helps accelerate clinical therapy development, foster the discovery of new biomarkers, and create novel diagnostic tools These integrated capabilities will […]

The post Roche enters into a definitive merger agreement to acquire PathAI to transform AI-driven diagnostics first appeared on Tissuepathology.com.

Indica Labs Announces February Webinar

Erica Goodpaster — Mon, 02 Feb 2026 14:12:59 +0000

Indica Labs: Learn the fundamentals of the HALO GraphQL API and how to design, develop, and implement time-saving automations Designing and Developing Automated Solutions Using the HALO GraphQL API Date: 19 February 2026 Time: 8:00 – 9:00 PST | 11:00 – 12:00 EST | 16:00 – 17:00 GMT Location: Webinar Register Now Summary This presentation introduces the foundational […]

The post Indica Labs Announces February Webinar first appeared on Tissuepathology.com.

Indica Labs: Characterizing Immune and Cancer Cell Proximity and Distribution in the Tumor Microenvironment using HALO Spatial Analysis Tools

Erica Goodpaster — Mon, 15 Dec 2025 12:44:41 +0000

From Indica Labs: Spatial analysis of the tumor microenvironment provides critical insight into how cancer, immune, and stromal cells interact, helping researchers better understand disease behavior and therapeutic response. Indica Labs’ HALO Spatial Analysis module enables these investigations across diverse biological contexts by offering multiple algorithms to quantify cell proximity, infiltration, and spatial patterns using […]

The post Indica Labs: Characterizing Immune and Cancer Cell Proximity and Distribution in the Tumor Microenvironment using HALO Spatial Analysis Tools first appeared on Tissuepathology.com.

A Philadelphia jury reached $35 million verdict against Main Line Health and Penn Medicine for cancer misdiagnosis

Erica Goodpaster — Mon, 08 Dec 2025 12:47:56 +0000

A woman underwent a total hysterectomy at Penn based on a cancer misdiagnosis at Lankenau Medical Center. The verdict is the largest so far this year in Philadelphia. A Philadelphia jury reached $35 million verdict last week against Main Line Health and the University of Pennsylvania Health System for a cancer misdiagnosis that led a […]

The post A Philadelphia jury reached $35 million verdict against Main Line Health and Penn Medicine for cancer misdiagnosis first appeared on Tissuepathology.com.

Proscia Achieves SOC 2 Type II Certification, Strengthening Enterprise Trust

Erica Goodpaster — Thu, 04 Dec 2025 13:51:20 +0000

Compliance with independent security standards comes as Proscia accelerates digital pathology deployments at scale PHILADELPHIA – December 3, 2025 – Proscia®, a pathology AI company, has successfully completed its SOC 2 Type II audit. This milestone underscores the company’s enterprise-grade security and operational rigor, reinforcing its role as the partner of choice for large-scale digital pathology […]

The post Proscia Achieves SOC 2 Type II Certification, Strengthening Enterprise Trust first appeared on Tissuepathology.com.

Could Lithium Explain — and Treat — Alzheimer’s Disease?

Erica Goodpaster — Fri, 08 Aug 2025 12:07:23 +0000

Study: Lithium loss ignites Alzheimer’s, but lithium compound can reverse disease in mice What is the earliest spark that ignites the memory-robbing march of Alzheimer’s disease? Why do some people with Alzheimer’s-like changes in the brain never go on to develop dementia? These questions have bedeviled neuroscientists for decades. Now, a team of researchers at Harvard […]

The post Could Lithium Explain — and Treat — Alzheimer’s Disease? first appeared on Tissuepathology.com.